These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 7658269)

  • 21. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
    Guo CY; Ronen GM; Atkinson SA
    Epilepsia; 2001 Sep; 42(9):1141-7. PubMed ID: 11580761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
    Beshyah SA; Thomas E; Kyd P; Sharp P; Fairney A; Johnston DG
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone secretion in poorly growing children with renal hypophosphataemic rickets.
    Saggese G; Baroncelli GI; Bertelloni S; Perri G
    Eur J Pediatr; 1994 Aug; 153(8):548-55. PubMed ID: 7957399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease.
    Lilova M; Kaplan BS; Meyers KE
    Pediatr Nephrol; 2003 Jan; 18(1):57-61. PubMed ID: 12488992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets.
    Haffner D; Nissel R; Wühl E; Mehls O
    Pediatrics; 2004 Jun; 113(6):e593-6. PubMed ID: 15173542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial hypophosphatemic rickets: bone mass measurements in children following therapy with calcitriol and supplemental phosphate.
    Block JE; Piel CF; Selvidge R; Genant HK
    Calcif Tissue Int; 1989 Feb; 44(2):86-92. PubMed ID: 2492895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal handling of phosphate can predict height velocity during growth hormone therapy for short children.
    Nishiyama S; Ikuta M; Nakamura T; Tomoeda S; Matsuda I
    J Clin Endocrinol Metab; 1992 Apr; 74(4):906-9. PubMed ID: 1548358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH-deficient adults: the effects on renal phosphate handling, bone turnover and bone mineral mass.
    Valk NK; Erdtsieck RJ; Algra D; Lamberts SW; Pols HA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):317-24. PubMed ID: 7586601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal hypophosphatemic rickets. Growth and mineral metabolism after treatment with calcitriol (1,25-dihydroxyvitamin D3) and phosphate supplementation.
    Tsuru N; Chan JC; Chinchilli VM
    Am J Dis Child; 1987 Jan; 141(1):108-10. PubMed ID: 3788870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.
    Antoniazzi F; Bertoldo F; Mottes M; Valli M; Sirpresi S; Zamboni G; Valentini R; Tató L
    J Pediatr; 1996 Sep; 129(3):432-9. PubMed ID: 8804334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of growth hormone therapy on bone metabolism of growth hormone deficient children.
    Stamoyannou L; Karachaliou F; Gioureli E; Voskaki E; Mengreli C; Bartsocas CS; Koutselinis A
    Eur J Pediatr; 1997 Aug; 156(8):592-6. PubMed ID: 9266187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
    Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
    J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of short-term insulin-like growth factor-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man.
    Bianda T; Hussain MA; Glatz Y; Bouillon R; Froesch ER; Schmid C
    J Intern Med; 1997 Feb; 241(2):143-50. PubMed ID: 9077371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
    Alon U; Chan JC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.
    Seikaly MG; Quigley R; Baum M
    Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human growth hormone replacement therapy and bone metabolism in children.
    Zamboni G; Antoniazzi F; Tatò L
    J Pediatr Endocrinol; 1993; 6(1):33-7. PubMed ID: 8374686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ; Boniface AM; Schranck FW; Rupich RC; Whyte MP
    J Bone Miner Res; 1992 Jun; 7(6):583-97. PubMed ID: 1414477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.